Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Some treatments like minoxidil, finasteride, and dutasteride are effective for hair loss, but there's no agreed best treatment.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Confirm testosterone levels with advanced tests to avoid unnecessary procedures.

Men using 5-alpha reductase inhibitors for prostate issues may have a slightly higher risk of blood clots.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

Equilibrium dialysis can accurately measure testosterone levels when lab results are inconsistent.

More effective methods are needed to prevent hair loss from chemotherapy.

Combining scalp acupoint catgut embedding with 5% minoxidil may help treat male pattern baldness.

PRP works faster and is a safe alternative to steroids for treating alopecia areata.

Finasteride may increase stroke risk in people with clotting tendencies.

Arsenic trioxide effectively treats APL, improving survival rates despite its toxicity.

Antiandrogens don't help with COVID-19 and aren't recommended.

PHIL can successfully treat scalp arteriovenous fistulas after hair transplants.

Some treatments for hereditary hair loss are effective but vary in results and side effects; new therapies show promise but need more research.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

Oral contraceptives and antiandrogens are the best treatments for hirsutism.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

New and existing treatments for hair loss show promise, with some being more effective for men and others for women.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

Intradermotherapy is a safe and effective short-term treatment for hair loss.